RYENX | VENAX | RYENX / VENAX | |
Total Expense Ratio | 1.65 | 0.09 | 1,833% |
Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
Fund Existence | 21 years | 21 years | - |
Gain YTD | 0.568 | 0.921 | 62% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.3M | 8.11B | 0% |
Annual Yield % from dividends | 4.31 | 3.27 | 132% |
Returns for 1 year | -6.21 | -4.70 | 132% |
Returns for 3 years | 22.56 | 21.52 | 105% |
Returns for 5 years | 152.74 | 146.87 | 104% |
Returns for 10 years | 5.94 | 17.86 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCLLX | 16.98 | 0.16 | +0.95% |
Goldman Sachs Enhanced U.S. Equity C | |||
VSTSX | 295.41 | 2.52 | +0.86% |
Vanguard Total Stock Mkt Idx Instl Sel | |||
PFPWX | 56.39 | 0.32 | +0.57% |
Parnassus Value Equity Institutional | |||
JGYAX | 12.95 | 0.06 | +0.47% |
JHancock Global Shareholder Yield A | |||
WCERX | 10.94 | -0.01 | -0.09% |
Virtus Westchester Event-Driven Fd A |